Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:123:279-313.
doi: 10.1016/bs.irn.2015.05.016. Epub 2015 Jun 22.

Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction

Jody Mayfield  1 , Yuri A Blednov  2 , R Adron Harris  2
Affiliations
Review

Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction

Jody Mayfield et al. Int Rev Neurobiol. 2015.

Abstract

G protein-coupled inwardly rectifying potassium (GIRK) channels are widely expressed throughout the brain and mediate the inhibitory effects of many neurotransmitters. As a result, these channels are important for normal CNS function and have also been implicated in Down syndrome, Parkinson's disease, psychiatric disorders, epilepsy, and drug addiction. Knockout mouse models have provided extensive insight into the significance of GIRK channels under these conditions. This review examines the behavioral and genetic evidence from animal models and genetic association studies in humans linking GIRK channels with CNS disorders. We further explore the possibility that subunit-selective modulators and other advanced research tools will be instrumental in establishing the role of individual GIRK subunits in drug addiction and other relevant CNS diseases and in potentially advancing treatment options for these disorders.

Keywords: Anxiety; Cocaine; Depression; Down syndrome; Epilepsy; Ethanol; Genetic association studies; Knockout mice; Opioids; Parkinson's disease; Schizophrenia; Sedative–hypnotics.

PubMed Disclaimer

References

    1. Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, et al. Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: Secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol and Alcoholism. 2011;46(3):312–317. http://dx.doi.org/10.1093/alcalc/agr017. - DOI - PubMed
    1. Addolorato G, Leggio L, Hopf FW, Diana M, Bonci A. Novel therapeutic strategies for alcohol and drug addiction: Focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2012;37(1):163–177. http://dx.doi.org/10.1038/npp.2011.216. - DOI - PMC - PubMed
    1. Anderson GR, Posokhova E, Martemyanov KA. The R7 RGS protein family: Multi-subunit regulators of neuronal G protein signaling. Cell Biochemistry and Biophysics. 2009;54(1–3):33–46. http://dx.doi.org/10.1007/s12013-009-9052-9. - DOI - PMC - PubMed
    1. Arora D, Haluk DM, Kourrich S, Pravetoni M, Fernandez-Alacid L, Nicolau JC, et al. Altered neurotransmission in the mesolimbic reward system of Girk mice. Journal of Neurochemistry. 2010;114(5):1487–1497. http://dx.doi.org/10.1111/j.1471-4159.2010.06864.x. - DOI - PMC - PubMed
    1. Aryal P, Dvir H, Choe S, Slesinger PA. A discrete alcohol pocket involved in GIRK channel activation. Nature Neuroscience. 2009;12(8):988–995. http://dx.doi.org/10.1038/nn.2358. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances